IntraFuse announced the United States Patent and Trademark office has granted it a key patent for its FlexThread intramedullary fracture fixation system. According to ...
To determine if use of an osteogenic agent (rhBMP-2) at the time of surgical treatment for tibial pseudarthosis in NF1 patients will result in improved bone healing when compared to NF1 patients ...
Please provide your email address to receive an email when new articles are posted on . The FDA announced it has classified the in vivo-cured intramedullary fixation rod into class II or special ...
The future of fracture fixation with novel side-specific nails featuring variable angle locking technology Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the ...
SOLOTHURN, Switzerland--(BUSINESS WIRE)--DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced the availability of Expert Tibial Nail PROtect, the only tibial nail with a ...